Study | Year | Country | Type of study | Sample size | Main operation | Definition of AKI | Total AKI incidence | Adjustment |
---|---|---|---|---|---|---|---|---|
Ranucci [14] | 2013 | USA | Cohort | 4440 | CABG | A | 21.7% | Age, EF, MI, congestive heart failure, previous operation, urgent operation, creatinine, CPB duration, nadir HCT |
Valve Surgery | ||||||||
Ko [9] | 2012 | USA | Cohort | 2133 | CABG | A | 32.0% | None |
AVR | ||||||||
Mcllroy [21] | 2012 | USA | Cohort | 644 | CABG | A | 21.9% | Age, BMI, CPB duration, procedure type, N-acetylcysteine administration, modified EuroSCORE |
Valve Surgery | ||||||||
Greason [11] | 2012 | USA | Cohort | 642 | AVR | A | 22.7% | None |
Andersen [10] | 2012 | USA | Case-control | 285 | Aorta replacement | B (R) | 31.0% | Age, sex, BMI, eGFR, hypertension, CHF, diabetes, CPB duration, EF, hemoglobin, aprotinin exposure |
CABG | ||||||||
Mehta [22] | 2011 | USA | Case-control | 2441 | CABG | A | 17.1% | Age, sex, race, BMI, diabetes, CHF, MI, EF, hypertension, contrast volume and type, cardiogenic shock, cross-clamp time, creatinine, hemoglobin |
Medalion [17] | 2010 | Israel | Case-control | 395 | CABG | B (R) | 13.6% | None |
Hennessy [16] | 2010 | USA | Cohort | 197 | Valve Surgery | B (I) | 6.6% | None |
CABG | ||||||||
Del Duca [15] | 2007 | Canada | Case-control | 649 | CABG | C | 24.0% | Age, CPB duration, baseline GFR |
Valve Surgery |